Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto L Horenstein

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2015
CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell ProliferationFabio Morandi, Alberto L Horenstein, Antonella Chillemi, et al.
Human Antibodies|December 31, 2016
Antibody mimicry, receptors and clinical applicationsAlberto L Horenstein, Antonella Chillemi, Valeria Quarona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2011
Stable coordination of the inhibitory Ca2+ ion at the metal ion-dependent adhesion site in integrin CD11b/CD18 by an antibody-derived ligand aspartate: implications for integrin regulation and structure-based drug designBhuvaneshwari Mahalingam, Kaouther Ajroud, José Luis Alonso, et al.
Oncotarget|September 3, 2015
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferationFabio Morandi, Barbara Morandi, Alberto L Horenstein, et al.
British Journal of Haematology|February 11, 2021
Molecular dynamics of targeting CD38 in multiple myelomaFabio Malavasi, Angelo C Faini, Fabio Morandi, et al.
Blood|October 15, 2011
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathSara Serra, Alberto L Horenstein, Tiziana Vaisitti, et al.
Annals of the New York Academy of Sciences|July 23, 2014
Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow nicheValeria Quarona, Valentina Ferri, Antonella Chillemi, et al.
Cells|September 23, 2015
NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma ModelAlberto L Horenstein, Antonella Chillemi, Valeria Quarona, et al.
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunityFabio Malavasi, Silvia Deaglio, Enza Ferrero, et al.
Oncotarget|September 17, 2017
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formationFederica Costa, Denise Toscani, Antonella Chillemi, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2015
CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell ProliferationFabio Morandi, Alberto L Horenstein, Antonella Chillemi, et al.
Human Antibodies|December 31, 2016
Antibody mimicry, receptors and clinical applicationsAlberto L Horenstein, Antonella Chillemi, Valeria Quarona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2011
Stable coordination of the inhibitory Ca2+ ion at the metal ion-dependent adhesion site in integrin CD11b/CD18 by an antibody-derived ligand aspartate: implications for integrin regulation and structure-based drug designBhuvaneshwari Mahalingam, Kaouther Ajroud, José Luis Alonso, et al.
Oncotarget|September 3, 2015
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferationFabio Morandi, Barbara Morandi, Alberto L Horenstein, et al.
British Journal of Haematology|February 11, 2021
Molecular dynamics of targeting CD38 in multiple myelomaFabio Malavasi, Angelo C Faini, Fabio Morandi, et al.
Blood|October 15, 2011
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathSara Serra, Alberto L Horenstein, Tiziana Vaisitti, et al.
Annals of the New York Academy of Sciences|July 23, 2014
Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow nicheValeria Quarona, Valentina Ferri, Antonella Chillemi, et al.
Cells|September 23, 2015
NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma ModelAlberto L Horenstein, Antonella Chillemi, Valeria Quarona, et al.
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunityFabio Malavasi, Silvia Deaglio, Enza Ferrero, et al.
Oncotarget|September 17, 2017
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formationFederica Costa, Denise Toscani, Antonella Chillemi, et al.
Pageof 5